Ameriprise’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $971M | Sell |
|
|||||
|
2025
Q1 | $1.08B | Buy |
|
|||||
|
2024
Q4 | $812M | Buy |
|
|||||
|
2024
Q3 | $871M | Sell |
|
|||||
|
2024
Q2 | $963M | Sell |
|
|||||
|
2024
Q1 | $930M | Sell |
|
|||||
|
2023
Q4 | $1.02B | Sell |
|
|||||
|
2023
Q3 | $1.02B | Sell |
|
|||||
|
2023
Q2 | $1.06B | Sell |
|
|||||
|
2023
Q1 | $1.07B | Sell |
|
|||||
|
2022
Q4 | $1.03B | Sell |
|
|||||
|
2022
Q3 | $1.17B | Sell |
|
|||||
|
2022
Q2 | $1.29B | Sell |
|
|||||
|
2022
Q1 | $1.29B | Buy |
|
|||||
|
2021
Q4 | $969M | Buy |
|
|||||
|
2021
Q3 | $615M | Buy |
|
|||||
|
2021
Q2 | $552M | Buy |
|
|||||
|
2021
Q1 | $412M | Buy |
|
|||||
|
2020
Q4 | $193M | Sell |
|
|||||
|
2020
Q3 | $228M | Sell |
|
|||||
|
2020
Q2 | $373M | Sell |
|
|||||
|
2020
Q1 | $517M | Sell |
|
|||||
|
2019
Q4 | $527M | Buy |
|
|||||
|
2019
Q3 | $403M | Sell |
|
|||||
|
2019
Q2 | $448M | Buy |
|
|||||
|
2019
Q1 | $435M | Sell |
|
|||||
|
2018
Q4 | $721M | Sell |
|
|||||
|
2018
Q3 | $1.11B | Sell |
|
|||||
|
2018
Q2 | $988M | Buy |
|
|||||
|
2018
Q1 | $914M | Buy |
|
|||||
|
2017
Q4 | $787M | Sell |
|
|||||
|
2017
Q3 | $826M | Sell |
|
|||||
|
2017
Q2 | $826M | Sell |
|
|||||
|
2017
Q1 | $901M | Sell |
|
|||||
|
2016
Q4 | $641M | Buy |
|
|||||
|
2016
Q3 | $758M | Sell |
|
|||||
|
2016
Q2 | $776M | Sell |
|
|||||
|
2016
Q1 | $747M | Sell |
|
|||||
|
2015
Q4 | $1.21B | Sell |
|
|||||
|
2015
Q3 | $1.06B | Buy |
|
|||||
|
2015
Q2 | $1.22B | Sell |
|
|||||
|
2015
Q1 | $1.17B | Buy |
|
|||||
|
2014
Q4 | $1.11B | Sell |
|
|||||
|
2014
Q3 | $1.07B | Buy |
|
|||||
|
2014
Q2 | $670M | Sell |
|
|||||
|
2014
Q1 | $575M | Buy |
|
|||||
|
2013
Q4 | $579M | Buy |
|
|||||
|
2013
Q3 | $452M | Buy |
|
|||||
|
2013
Q2 | $366M | Buy |
|